Santa Rosa, CA – April 26, 2006 – EcoNugenics®, a leading dietary supplement company, announced today that the United States Patent and Trademark Office (USPTO) has issued the company US Patent No. 7,026,302. This important new patent protects the use of modified alginates and modified pectins in providing support to those suffering from a wide range of diseases that may be caused or aggravated by heavy metals, environmental toxins or cholesterol.
EcoNugenics® currently markets two products that are protected by this patent and earlier patents # 6,274,566 and #6,462,029: PectaSol® Modified Citrus Pectin and PectaSol® Chelation Complex.
“This is excellent news! We are gratified that the US Patent Office has issued this patent, said Isaac Eliaz, MD, L.Ac., President and Founder of EcoNugenics®. “This issuance provides further validation of our strategy and gives us confidence to continue our research and development work on creating a product to address the rising prevalence of diabetes.”
EcoNugenics® was founded in 1995 with a commitment to offering premium dietary supplements based on the best of modern science integrated with the ancient wisdom of traditional and complementary therapies. EcoNugenics® is committed to five basic principles, which include innovation in product formulation, thorough scientific research, ongoing clinical validation, customer education/empowerment and superior quality control. For more information contact Connie St. John at 415-454-2243.
# # #